EUVIMEDOntdek EUVIMED
Crossref

Artemether Ameliorates Non‐Alcoholic Steatohepatitis by Restraining Cross‐Talk Between Lipotoxicity‐Induced Hepatic Hepatocytes and Macrophages

Jia Xu, Xiaoyan Cheng, Qi Wang, Feng Zhang, Xinxin Ren, Kunlun Huang, Yanzhou Hu, Ruxin Gao, Kun Yang, Jingya Yin, Bingqing Yang, Xiaoyun He and 1 more

Phytotherapy Research · 2025

DOI: 10.1002/ptr.8393 ↗

At a glance

Journal article in Phytotherapy Research, 2025. Written by Jia Xu and 12 co-authors. Institution: Key Laboratory of Precision Nutrition and Food Quality, Key Laboratory of Functional Dairy, Ministry of Education; College of Food Science and Nutrit…. Major MEDLINE topics: Non-alcoholic Fatty Liver Disease, Hepatocytes, Macrophages, Artemether. Cited 7 times so far (Crossref); 38 references. Funded by: National Natural Science Foundation of China, Key Research and Development Program Projects of Hebei Province, Data Center of Management Science, National Natural Science Foundation of China - Peking University.

SamenvattingSubjectsBibliografische gegevensCiteRelated studies

Abstract (original language)

Non‐alcoholic steatohepatitis (NASH) has no effective treatment drug. Our previous study initially found that artemether (Art) treatment significantly attenuates NSAH by regulating liver lipid metabolism. This study further elucidates new mechanisms of Art in improving liver inflammation and provides evidence for drug repurposing. Herein, we utilized HFHF diet‐induced animal model and macrophage models to detect the mechanisms of Art in NASH. We confirmed that Art significantly reduced hepatic steatosis, injury, and fibrosis in a high‐fat high‐fructose (HFHF) diet‐induced animal model. Art significantly suppressed the activation of inflammatory macrophages and secretion of pro‐inflammatory cytokine (IL‐1β) by reducing serum double‐stranded DNA (dsDNA) levels and triggering the AIM2/Caspase‐1/GSDMD signaling in vivo. dsDNA‐induced Caspase‐1 and PI‐positive cells pyroptosis, AIM2 inflammasome activation, IL‐1β, and IL‐18 secretion increase were inhibited by Art in vitro. Furthermore, we found Art effectively suppressed mitochondrial DNA (mtDNA), a typical form of dsDNA, released from free fatty acid (FFA)‐stressed hepatocytes, which further inhibited AIM2 inflammasome mediated‐pyroptosis through decreasing the cleavage of Caspase‐1/GSDMD/IL‐1β. Moreover, inhibition of the AIM2 gene partly reversed the inhibitory effect of Art on macrophage pyroptosis. Impaired mitochondrial structure and function were confirmed in FFA‐stressed hepatocytes and the HFHF‐diet‐induced NASH mouse model, which was reversed by Art treatment. The present study provides evidence for Art as a potential anti‐pyroptosis therapeutic agent for NASH treatment.

Subjects

MeSH terms (MEDLINE)

Non-alcoholic Fatty Liver DiseaseHepatocytesMacrophagesArtemetherAnimalsMiceMaleDiet, High-FatMice, Inbred C57BLCaspase 1InflammasomesInterleukin-1betaPyroptosisDNA, MitochondrialDisease Models, AnimalDNA-Binding ProteinsLipid MetabolismInterleukin-18LiverSignal Transduction

Author keywords

NASHPyroptosisartemether

Substances

ArtemetherCaspase 1InflammasomesInterleukin-1betaDNA, MitochondrialDNA-Binding ProteinsAim2 protein, mouseInterleukin-18

Authors and institutions

  • Key Laboratory of Precision Nutrition and Food Quality, Key Laboratory of Functional Dairy, Ministry of Education; College of Food Science and Nutritional Engineering, China Agricultural University, Beijing, China.
  • Institute of Analysis and Testing, Beijing Academy of Science and Technology, Beijing, China.
  • Center of Liver Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
  • Beijing Key Laboratory of Emerging Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
  • Department of Pathology, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
  • Department of Clinical Laboratory, Beijing Ditan Hospital, Capital Medical University, Beijing, China.

ORCID profiles: Yue Li

Funding

  • National Natural Science Foundation of China
  • Key Research and Development Program Projects of Hebei Province
  • Data Center of Management Science, National Natural Science Foundation of China - Peking University

Cite

APA

Xu, J., Cheng, X., Wang, Q., Zhang, F., Ren, X., Huang, K., Hu, Y., Gao, R., Yang, K., Yin, J., Yang, B., He, X., & Li, Y. (2025). Artemether Ameliorates Non‐Alcoholic Steatohepatitis by Restraining Cross‐Talk Between Lipotoxicity‐Induced Hepatic Hepatocytes and Macrophages. Phytotherapy Research. https://doi.org/10.1002/ptr.8393

Vancouver

Xu J, Cheng X, Wang Q, Zhang F, Ren X, Huang K, et al. Artemether Ameliorates Non‐Alcoholic Steatohepatitis by Restraining Cross‐Talk Between Lipotoxicity‐Induced Hepatic Hepatocytes and Macrophages. Phytotherapy Research. 2025. doi:10.1002/ptr.8393

BibTeX
@article{Xu2025,
  author = {Xu, Jia and Cheng, Xiaoyan and Wang, Qi and Zhang, Feng and Ren, Xinxin and Huang, Kunlun and Hu, Yanzhou and Gao, Ruxin and Yang, Kun and Yin, Jingya and Yang, Bingqing and He, Xiaoyun and Li, Yue},
  title = {Artemether Ameliorates Non‐Alcoholic Steatohepatitis by Restraining Cross‐Talk Between Lipotoxicity‐Induced Hepatic Hepatocytes and Macrophages},
  journal = {Phytotherapy Research},
  year = {2025},
  doi = {10.1002/ptr.8393}
}
Start for free →